cannabinoid compounds


InMed Launches Study on Cannabis-Based COPD Therapy

InMed Pharmaceuticals is expanding its product line by initiating studies on a potential treatment for chronic obstructive pulmonary disease (COPD). The clinical stage company specializes in the development of therapeutic options based on cannabis, and will launch a new program designed to discover and assess cannabinoid compounds able to treat COPD. InMed announced that […]